JW Pharmaceutical Corporation (001067.KS) Fundamentals
As of May 23, 2026
TL;DR — JW Pharmaceutical Corporation (001067.KS) fundamentals as of May 23, 2026
JW Pharmaceutical Corporation (001067.KS) trades at a trailing P/E of 0.0x and a P/B of 0.00x. Return on equity is 16.7%, return on invested capital is 15.8%, and the company carries a debt-to-equity ratio of 0.15. The current ratio sits at 1.42, free cash flow yield is 10.0%, and the dividend yield is 117.0%. MIXED — passes most quality screens but at least one flag warrants a closer look.
For intrinsic value (DCF, owner earnings, Graham number) and the full 5-pillar score, see the 001067.KS overview page.
Full Fundamentals Table
Every key indicator we track for 001067.KS fundamentals, grouped by category. Industry median is shown where a sector classification is available.
| Metric | 001067.KS | Sector median | What it measures |
|---|---|---|---|
| Revenue (TTM) | View full statement | - | Trailing twelve-month total revenue |
| Net Income (TTM) | View full statement | - | Bottom-line profit after taxes and interest |
| Free Cash Flow (TTM) | View full statement | - | Cash from operations minus CapEx |
| EPS (TTM) | N/A | - | Earnings per diluted share |
| ROE | 16.7% | - | Return on Equity — net income / shareholder equity |
| ROA | 10.2% | - | Return on Assets — net income / total assets |
| ROIC | 15.8% | - | Return on Invested Capital — NOPAT / (debt + equity) |
| P/E (Trailing) | 0.0x | - | Price / earnings — how many years of profit to recoup price |
| P/B | 0.00x | - | Price / book value — premium over net assets |
| P/S | 0.00x | - | Price / sales — useful when earnings are noisy |
| EV/EBITDA | 7.0x | - | Enterprise value / EBITDA — capital-structure neutral |
| Debt / Equity | 0.15 | - | Leverage — lower = less reliance on debt |
| Current Ratio | 1.42 | - | Current assets / current liabilities — short-term liquidity |
| Dividend Yield | 117.0% | - | Annual dividend / current price |
5-Year Trend
Indexed revenue growth path for 001067.KS over the past five fiscal years (base = 100). Used as a quick sanity check on whether the top line is compounding or stalling.
Trend indexed from 1-year revenue growth rate. Full statement available in the analyst tier.
Industry Comparison
Sector classification is missing for this ticker, so industry medians are not yet available. We are backfilling sector data on every cache refresh.
Quality Triple Check
Piotroski F-Score
Nine-point checklist for accounting quality and operational efficiency
6/9
PASS
Beneish M-Score
Earnings-manipulation detector — below -2.22 is healthy
-2.89
PASS
Altman Z-Score
Bankruptcy-risk model — above 2.99 is "safe zone"
2.38
FLAG
Verdict: MIXED — passes most quality screens but at least one flag warrants a closer look.
Next steps
- View the full 001067.KS overview for intrinsic value (DCF), margin of safety, and the 5-pillar VM Score.
- Check the 001067.KS beta page for volatility vs the S&P 500.
- Look at the 001067.KS P/E ratio page for the 10-year valuation context.
- Dig into the 001067.KS debt-to-equity page for leverage trends.
- Run your own model in the DCF calculator.
Frequently asked about 001067.KS fundamentals
What are the key fundamentals for JW Pharmaceutical Corporation (001067.KS)?↓
The core 001067.KS fundamentals are P/E 0.0, ROE 16.7%, ROIC 15.8%, debt/equity 0.15, and dividend yield 117.0%. The complete ratio table on this page covers revenue, net income, FCF, EPS, ROA, P/B, P/S, EV/EBITDA, and current ratio.
How does 001067.KS compare to its sector peers?↓
Industry comparison requires a sector classification — we are still ingesting peer medians for this name.
Does 001067.KS pass the Quality Triple Check?↓
001067.KS passes 2 of 3 quality screens (Piotroski F-Score, Beneish M-Score, Altman Z-Score). Detailed verdict above.
How is "fundamentals" different from intrinsic value?↓
Fundamentals describe what the business looks like today: profit, cash flow, leverage, returns on capital. Intrinsic value uses those fundamentals as inputs to a DCF (or similar model) and discounts the future cash flows back to today. Use both — fundamentals tell you whether a business is healthy, intrinsic value tells you whether the price is fair.
How often does ValueMarkers update 001067.KS fundamentals?↓
Cached financial statements refresh every 12 hours. The ratio table on this page is rebuilt every 6 hours via Next.js ISR, and the underlying FMP data refreshes on each new earnings release.